Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. (Q34048935)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

Gregorio Catalán-Uribarrena

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Iñigo Pomposo Gaztelu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Gaizka Bilbao-Barandica

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

José Undabeitia-Huertas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Edurne Ruiz de Gopegui-Ruiz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Lara Galbarriatu-Gutiérrez

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Manuel Canales-Llantada

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jon Aurrecoechea-Obieta

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Alfonso Igartua-Azkune

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Guillermo Carbayo-Lozano

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

15 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Acta Neurochirurgica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

154

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

211-22; discussion 222

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002506%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

'Recurrent' glioblastoma multiforme, when should we reoperate?

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Assessing observational studies of medical treatments

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Evaluation of malignant glioma patients during the postirradiation period

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Advanced MRI in the management of adult gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

The ABCs of measuring intracerebral hemorrhage volumes.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Editorial: on the road to multi-modal and pluri-disciplinary treatment of glioblastomas

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Temozolomide in combination with other cytotoxic agents

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Level of evidence in the literature concerning brain tumor resection

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Glioma extent of resection and its impact on patient outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

From randomized controlled trials to observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Clinical impact of adjuvant chemotherapy in glioblastoma multiforme : a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1199-7

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34048935&oldid=2196171973"